JPRN-UMIN000010371尚未招募未知
Study of zonisamide ( TRERIEF® tablet 25mg ) to tremor in patients with early Parkinson's disease. - Study of zonisamide to tremor in patients with early Parkinson's disease.
Department of Neurology, University of Yamanashi0 个研究点目标入组 10 人开始时间: 2013年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with Parkinsonism other than Parkinson's disease 2) Patients who have taken zonisamide 3) Patients with dementia : [Mini Mental State Examination (MMSE) score is less than 22points 4) Patients with severs disease of heart, renal, liver, and other life-threatening diseases 5) Patients who are determined as unfit for the study by attending physicians for reasons other than those stated above
研究者
相似试验
进行中（未招募）
2 期
Study on efficacy and safety of zonisamide in at-risk subjects of Lewy body diseaseJPRN-jRCTs041190126Katsuno Masahisa30
已完成
4 期
A Clinical Trial to evaluate the safety and efficacy of zonisamide an antiepileptic drug in treatment patients with seizures (Fits). This is a postmarketing study to further confirm the safety and efficacy in large number of patients in the approved types of seizures.CTRI/2010/091/002925Eisai Pharmaceuticals India Private Limited.1st Floor, B-Wing, Marwah Centre, Krishanlal Marwah Marg, Andheri East, Mumbai - 400072655
进行中（未招募）
不适用
An Open Label Study of ZONEGRANTM Zonisamide in patients with partial onset seizuresEpilepsy patients with partial onset seizures with or without secondary generalizationMedDRA version: 9.1Level: HLTClassification code 10034093Term: Partial simple seizures NECEUCTR2005-001982-33-ITEISAI LTD UK
已完成
不适用
A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.Partial, Generalized and Combined SeizuresNCT01283256Eisai Inc.655
已完成
3 期
A Study of Zonisamide to Prevent Olanzapine-Associated Weight GainWeight GainNCT00363376Lindner Center of HOPE42